Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

NCT05217667 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Homozygous Familial Hypercholesterolemia

Interventions

DRUG: ARO-ANG 3 Injection

Sponsor

Arrowhead Pharmaceuticals